CD8A and Patent ductus arteriosus: Similarly, in advanced PDA patients, CD8+ TILs accumulate certain LCFAs with decreased ACADVL (encoding VLCAD) transcription, accelerating the lipotoxicity mediated by LCFAs and VLCFAs (9).